Skip to main content
SpringerLink
Log in

Sleeve Gastrectomy with Jejunal Bypass for the Treatment of Type 2 Diabetes Mellitus in Patients with Body Mass Index <35 kg/m2. A cohort study

  • Technical Innovation
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

The objective of this study was to evaluate sleeve gastrectomy with jejunal bypass (SGJB) as a surgical treatment for type 2 diabetes mellitus (T2DM) in patients with a body mass index (BMI) <35 kg/m2. This is a prospective cohort study. Patients with T2DM and BMI <35 kg/m2 who underwent SGJB between January 2009 and June 2011 at DIPRECA Hospital, in Santiago, and Hospital Base, Osorno, Chile were included. SGJB consists of creating a gastric tube, which preserves the pylorus, and performing a jejunoileal anastomosis 300 cm distal to the angle of Treitz. Excess weight loss (EWL) and complete or partial remission of T2DM were reported. Forty-nine patients met the inclusion criteria. The mean age was 49 years (36–62), and 53 % of patients were female. Mean preoperative BMI was 31.6 kg/m2 (25–34.9 kg/m2). Operation time was 123 ± 14 min, with 94.7 % of operations performed laparoscopically. Mean postoperative hospital stay was 2 days. Mean postoperative follow-up was 12 months. Median EWL at 1, 3, 6, 12, and 18 months postoperatively was 31.9 %, 56.9 %, 76.1 %, 81.5 %, and 76.1 %, respectively. Complete T2DM remission was achieved in 81.6 % of patients (40/49) and partial remission in 18.4 % (9/49). Forty of 41 patients (97.6 %) on oral hypoglycemic agents achieved complete T2DM remission, and 100 % of insulin-dependent patients stopped using insulin but were still being treated for T2DM. One patient experienced postoperative gastrointestinal bleeding. There were no deaths. SGJB is an effective treatment for T2DM in patients with BMI <35 kg/m2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–52.

    Article  PubMed  CAS  Google Scholar 

  2. MacDonald Jr KG, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg. 1997;1(3):213–20 (discussion: 220).

    Article  PubMed  Google Scholar 

  3. Ferchak CV, Meneghini LF. Obesity, bariatric surgery and type 2 diabetes—a systematic review. Diabetes Metab Res Rev. 2004;20:438–45.

    Article  PubMed  Google Scholar 

  4. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.e5.

    Article  PubMed  Google Scholar 

  5. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  PubMed  CAS  Google Scholar 

  6. Padwal RS. Review: bariatric surgery reduces weight and improves type 2 diabetes in adults. Evid Based Med. 2009;14(5):138.

    Article  PubMed  Google Scholar 

  7. Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 kg/m2: an integrative review of early studies. Obes Surg. 2010;20:776–90.

    Article  PubMed  CAS  Google Scholar 

  8. Peterli R, Wölnerhanssen B, Peters T, et al. Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg. 2009;250(2):234–41.

    Article  PubMed  Google Scholar 

  9. DePaula A, Stival A, Halpern A, et al. Surgical treatment of morbid obesity: mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy in 120 patients. Obes Surg. 2011;21(5):668–75.

    Article  PubMed  Google Scholar 

  10. Alamo M, Sepúlveda C, Zapata L. Vertical isolated gastroplasty with gastro-enteral bypass: preliminary results. Obes Surg. 2006;16(3):353–8.

    Article  Google Scholar 

  11. de Menezes Ettinger JE, Azaro E, Mello CA, et al. Analysis of the vertical isolated gastroplasty: a new bariatric operation. Obes Surg. 2006;16(9):1261–3; author reply 1263–4.

    Article  Google Scholar 

  12. Vandenbroucke JP, von Elm E, Altman DG, et al. STROBE initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med. 2007;147:W163–94.

    PubMed  Google Scholar 

  13. STROBE Statement. Strengthening the Reporting of Observational studies in Epidemiology. http://www.strobe-statement.org. Accessed 6 Apr 2011.

  14. American Diabetes Association Position Statement. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33 Suppl 1:S62–9.

    Article  Google Scholar 

  15. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Reviews/commentaries/ADA statements consensus statement. Diabetes Care. 2009;32:2133–5.

    Article  PubMed  Google Scholar 

  16. Robinson JD, Lupkiewicz SM, Palenik L, et al. Determination of ideal body weight for drug dosage calculations. Am J Hosp Pharm. 1983;40(6):1016–9.

    PubMed  CAS  Google Scholar 

  17. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. Proc R Soc Lond Biol. 1902;69:352–3.

    CAS  Google Scholar 

  18. Elrick H, Stimmler L, Hlad Jr CJ, et al. Plasma insulin response to oral and intravenous glucose administration. J Clin Invest. 1964;24:1076–82.

    CAS  Google Scholar 

  19. Neumiller JJ. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors. J Am Pharm Assoc (2003). 2009;49(Suppl 1):S16–29.

    Google Scholar 

  20. La Barre J. Sur les possibilités d'un traitement du diabetes par l'incrétine. Bull Acad R Med Belg. 1932;12:620–34.

    Google Scholar 

  21. Miller LJ, Malagelada JR, Taylor WF, et al. Intestinal control of human postprandial gastric function: the role of components of jejunoileal chyme in regulating gastric secretion and gastric emptying. Gastroenterology. 1981;80:763–9.

    PubMed  CAS  Google Scholar 

  22. Layer P, Holst JJ, Grandt D, et al. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci. 1995;40:1074–82.

    Article  PubMed  CAS  Google Scholar 

  23. Bose M, Oliván B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg. 2009;19(2):217–29.

    Article  PubMed  Google Scholar 

  24. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endocr Pract. 2008;14 Suppl 1:1–83.

    PubMed  Google Scholar 

  25. Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8.

    Article  PubMed  Google Scholar 

  26. Nocca D, Guillaume F, Noel P, et al. Impact of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on HbA1c blood level and pharmacological treatment of type 2 diabetes mellitus in severe or morbidly obese patients. Results of a multicenter prospective study at 1 year. Obes Surg. 2011;21(6):738–43.

    Article  PubMed  Google Scholar 

  27. Gill RS, Birch DW, Shi X, et al. Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review. Surg Obes Relat Dis. 2010;6(6):707–13.

    Article  PubMed  Google Scholar 

  28. Cohen RV, Schiavon CA, Pinheiro JS, et al. Duodenaljejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of two cases. Surg Obes Relat Dis. 2007;3:195–7.

    Article  PubMed  Google Scholar 

  29. DePaula AL, Macedo AL, Mota BR, et al. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc. 2009;23(6):1313–20.

    Article  PubMed  CAS  Google Scholar 

  30. Tinoco A, El-Kadre L, Aquiar L, et al. Short-term and mid-term control of type 2 diabetes mellitus by laparoscopic sleeve gastrectomy with ileal interposition. World J Surg. 2011;35(10):2238–44.

    Article  PubMed  Google Scholar 

  31. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239(1):1–11.

    Article  PubMed  Google Scholar 

  32. Rubino F, Forgione A, Cummings D, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741–9.

    Article  PubMed  Google Scholar 

  33. Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009;11(11):725–32.

    Article  PubMed  CAS  Google Scholar 

  34. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14:275–8.

    Article  PubMed  Google Scholar 

  35. Rodriguez-Grunert L, Neto MPG, Alamo M, et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal by-pass sleeve. Surg Obes Relat Dis. 2008;4:55–9.

    Article  PubMed  Google Scholar 

  36. Boza C, Muñoz R, Yung E, et al. Sleeve gastrectomy with ileal transposition (SGIT) induces a significant weight loss and diabetes improvement without exclusion of the proximal intestine. J Gastrointest Surg. 2011;15(6):928–34.

    Article  PubMed  Google Scholar 

  37. Cable CT, Colbert CY, Showalter T, et al. Prevalence of anemia after Roux-en-Y gastric bypass surgery: what is the right number? Surg Obes Relat Dis. 2011;7(2):134–9.

    Article  PubMed  Google Scholar 

  38. Simon SR, Zemel R, Betancourt S, et al. Hematologic complications of gastric bypass for morbid obesity. South Med J. 1989;82:1108–10.

    Article  PubMed  CAS  Google Scholar 

  39. Alvarez-Cordero R, Aragon-Viruette E. Post-operative complications in a series of gastric bypass patients. Obes Surg. 1992;2:87–9.

    Article  PubMed  Google Scholar 

  40. Halverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg. 1986;52:594–8.

    PubMed  CAS  Google Scholar 

  41. Loss AB, de Souza AA, Pitombo CA, et al. Analysis of the dumping syndrome on morbid obese patients submitted to Roux en Y gastric bypass. Rev Col Bras Cir. 2009;36(5):413–9.

    Article  PubMed  Google Scholar 

  42. Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16(24):2978–90.

    Article  PubMed  CAS  Google Scholar 

  43. Quigley E, Abu-Shanab A. Small intestinal bacterial overgrowth. Infect Dis Clin N Am. 2010;24:943–59.

    Article  Google Scholar 

  44. Greco M, De Micheli E, Lonardo A. Multifactorial hepatopathy in a patient with biliopancreatic diversion. Ann Ital Med Int. 2003;18(2):99–103. Italian.

    PubMed  Google Scholar 

  45. Papadia F, Marinari GM, Camerini G, et al. Short-term liver function after biliopancreatic diversion. Obes Surg. 2003;13(5):752–5.

    Article  PubMed  Google Scholar 

  46. Riordan SM, McIver CJ, Williams R. Liver damage in human small intestinal bacterial overgrowth. Am J Gastroenterol. 1998;93(2):234–7.

    Article  PubMed  CAS  Google Scholar 

  47. Reinshagen K, Zahn K, Buch C, et al. The impact of longitudinal intestinal lengthening and tailoring on liver function in short bowel syndrome. Eur J Pediatr Surg. 2008;18(4):249–53.

    Article  PubMed  CAS  Google Scholar 

  48. Martin GR, Beck PL, Sigalet DL. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J Gastroenterol. 2006;12(26):4117–29.

    PubMed  CAS  Google Scholar 

  49. Hartmann B, Thulesen J, Hansen BS, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47:370–6.

    Article  PubMed  Google Scholar 

  50. Santoro S, Milleo FQ, Malzoni CE. Enterohormonal changes alter digestive adaptation: five-year results of a surgical proposal to treat obesity and associated diseases. Obes Surg. 2008;18(1):17–26.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank the Archives Unit of Hospital Dipreca for facilitating the collection of data from patient records, the friends and colleagues who participated in revising and translating this article, and the residents and interns who assisted by calling patients, reviewing files, updating the database, and much more.

Disclosure

The authors declare that they have no conflicts of interest to disclose.

Author information

Authors and Affiliations

  1. Department of Surgery, Hospital DIPRECA, Santiago, Chile

    Munir Alamo, Matías Sepúlveda & Cristián Astorga

  2. Faculty of Medicine, Universidad Diego Portales, Santiago, Chile

    Munir Alamo & Matías Sepúlveda

  3. Department of Surgery, Hospital El Pino, Santiago, Chile

    José Gellona

  4. Faculty of Medicine, Universidad Andrés Bello, Santiago, Chile

    José Gellona

  5. Department of Surgery, Hospital Base de Osorno, Osorno, Chile

    Mauricio Herrera

  6. Department of Surgery, Universidad de La Frontera, Temuco, Chile

    Carlos Manterola

Authors
  1. Munir Alamo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matías Sepúlveda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Gellona
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mauricio Herrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Cristián Astorga
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carlos Manterola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Munir Alamo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alamo, M., Sepúlveda, M., Gellona, J. et al. Sleeve Gastrectomy with Jejunal Bypass for the Treatment of Type 2 Diabetes Mellitus in Patients with Body Mass Index <35 kg/m2. A cohort study. OBES SURG 22, 1097–1103 (2012). https://doi.org/10.1007/s11695-012-0652-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-012-0652-x

Keywords

Search

Navigation